Hims & Hers Health (HIMS) EPS (Basic) Growth (1y) (2020 - 2026)
Hims & Hers Health (HIMS) EPS (Basic) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.75 Bn | 40.09 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 32.76 Bn | 31.08 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.31 Bn | 19.65 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Hims & Hers Health | 7.78 Bn | 6.94 Bn | 480.80 Mn | -296.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -296.55% |
| Mar 31, 2026 | -280.96% |
| Dec 31, 2025 | -24.02% |
| Sep 30, 2025 | -80.03% |
| Jun 30, 2025 | 205.76% |
| Mar 31, 2025 | 327.59% |
| Dec 31, 2024 | 1,926.53% |
| Sep 30, 2024 | 1,069.02% |
| Jun 30, 2024 | 280.43% |
| Mar 31, 2024 | 207.27% |
| Dec 31, 2023 | 111.15% |
| Sep 30, 2023 | 60.77% |
| Jun 30, 2023 | 64.41% |
| Mar 31, 2023 | 39.39% |
| Dec 31, 2022 | 68.03% |
| Sep 30, 2022 | -15.19% |
| Jun 30, 2022 | -102.32% |
| Mar 31, 2022 | 76.12% |
| Dec 31, 2021 | 35.79% |
| Sep 30, 2021 | 72.68% |